Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic

Stroke

Volumn 28, Issue 9, 1997, Pages 1717-1723

  Chiou, Hung Yi ^a   Huang, Wei I ^b   Su, Che Long ^c   Chang, Shu Feng ^c   Hsu, Yi Hsiang ^b   Chen, Chien Jen ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c LOTUNG POH AI HOSPITAL   (Taiwan)

Author keywords

Arsenic; Cerebrovascular disorders; Hypertension; Risk factors; Water pollution

Indexed keywords

ARSENIC; WELL WATER;

ARTICLE; BRAIN INFARCTION; CONCENTRATION RESPONSE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TAIWAN; WATER CONTAMINATION; WATER POLLUTION;

EID: 0030820297     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.9.1717     Document Type: Article

References (47)

1. World Health Organization. Environmental Health Criteria 18: Arsenic. Geneva, Switzerland: World Health Organization; 1981.
2. US Public Health Service. Toxicological Profile for Arsenic. Washington DC: US Public Health Service: 1989.
3. Smith AH, Hopehayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, Wood R, Kosnett MJ, Smith MT. Cancer risks from arsenic in drinking water. Environ Health Perspect. 1992; 97:259-267.
4. Tseng WP. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect. 1977; 19:109-119.
5. Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY. Atherogenicity and carcinogenicity of high-arsenic artesian well water: multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis. 1988;8:452-460.
6. Tseng WP, Chen WY, Sung JL, Chen JS. A clinical study of blackfoot disease in Taiwan: an endemic peripheral vascular disease. Mem Coll Med Natl Taiwan Univ. 1961;7:1-18.
7. Cebrian ME, Albores A, Garcia-Vargas G, Del Razo LM, Ostrosky-Wegman P. Chronic arsenic poisoning in humans: the case of Mexico. In: Nriagu JO, ed. Advances in Environmental Science and Technology, Arsenic in the Environment, Part II: Human Health and Ecosystem Effects. New York, NY: John Wiley & Sons Inc; 1994;27:93-107.
8. Borgono JM, Vincent P, Venturino H, Infante A. Arsenic in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of the treatment plant. Environ Health Perspect. 1977;19:103-105.
9. Wang LF, Huang JZ. Chronic arsenicism from drinking water in some areas of Xinjiang, China. In: Nriagu JO, ed. Advances in Environmental Science and Technology, Arsenic in the Environment, Part II: Human Health and Ecosystem Effects. New York, NY: John Wiley & Sons Inc; 1994;27:159-172.
10. Lagerkvist BE, Linderholm H, Nordberg GF. Arsenic and Raynaud's phenomenon: vasospastic tendency and excretion of arsenic in smelter workers before and after the summer vacation. Int Arch Occup Environ Health. 1988;60:361-364.
11. Grobe JW. Peripheral circulatory disorders and acrocyanosis with arsenic [in German]. Berufs Dermatosen. 1976;24:78-84.
12. Wu MM, Kuo TL, Hwang YH, Chen CJ. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol. 1989;130:1123-1131.
13. Enterline PE, Marsh GM. Cancer among workers exposed to arsenic and other substances in a copper smelter. Am J Epidemiol 1982;116:895-911.
14. Lee-Feldstein A. Arsenic and respiratory cancer in humans: follow-up of copper smelter employees in Montana. J Natl Cancer Inst. 1983;70:601-610.
15. Jarp L, Pershagen G, Wall S. Cumulative arsenic exposure and lung cancer in smelter workers: a dose-response study. Am J Ind Med 1989;15:31-41.
16. Chen KP, Wu HY, Wu TC. Epidemiologic studies on blackfoot disease in Taiwan, III: physicochemical characteristics of drinking water in endemic blackfoot disease area. Mem Coll Med Natl Taiwan Univ. 1962;8:115-129.
17. Chang SF, Su CL, Chen ZY, Hung TP. Stroke incidence in Ilan, Taiwan. J Formos Med Assoc. 1995;94:30-35.
18. Breslow NE, Day NE. Statistical Methods in Cancer Research: The Analysis of Case-Control Studies. Geneva, Switzerland: World Health Organization; 1980;1:192-247.
19. Health Statistics, Republic of China. Taipei, Taiwan ROC: Department of Health, Executive Yuan; 1971-1996.
20. Hu HH, Chu FL, Wong WJ, Lo YK, Sheng WY. Trend in mortality from cerebrovascular disease in Taiwan. Stroke. 1986;17:1121-1124.
21. Chang CC, Chen CJ. Secular trend of mortality from cerebral infarction and cerebral hemorrhage in Taiwan, 1974-1988. Stroke. 1993;24:212-218.
22. Bonita R. Epidemiology of stroke. Lancet. 1992;339:342-344.
23. Curb JD, Abbott RD, MacLean CJ, Rodriguez BL, Burchfiel CM, Sharp DS, Ross GW, Yano K. Age-related changes in stroke risk in men with hypertension and normal blood pressure. Stroke. 1996;27: 819-824.
24. Hung TP. Changes in mortality from cerebrovascular disease and clinical pattern of stroke in Taiwan. J Formos Med Assoc. 1993;92: 687-696.
25. Hu HH, Sheng WY, Chu FL, Lan CF, Chiang BN. Incidence of stroke in Taiwan. Stroke. 1992;23:1237-1241.
26. Malmgren R, Warlow C, Bamford J, Sandercock P. Geographical and secular trends in stroke incidence. Lancet. 1987;2:1196-1200.
27. Bamford J, Sandercock P, Dennis M, Warlow C, Jones L, McPherson K, Vessey M, Fowler G, Molyneux A, Hughes T, Burn J, Wade D. A prospective study of acute cerebrovascular disease in the community: the Oxford Community Stroke Project, 1981-86, I - methodology, demography and incident cases of first ever stroke. J Neurol Neurosurg Psychiatry. 1988;51:1373-1380.
28. Broderick JP, Phillips SJ, Whisnant JP, O'Fallon WM, Bergstralh EJ. Incidence rates of stroke in the eighties: the end of the decline in stroke? Stroke. 1989;20:577-582.
29. Tanaka H, Hayashi M, Date C, Imai K, Asada M, Shoji H, Okazaki K, Yamamoto H, Yoshikawa K, Shimada T, Lee SL. Epidemiologic studies of stroke in Shibata, a Japanese provincial city: preliminary report on risk factors for cerebral infarction. Stroke. 1985;16: 773-780.
30. Li SC, Schoenberg BS, Wang CC, Cheng XM, Bolis CL, Wang KJ. Cerebrovascular disease in the Peoples' Republic of China: epidemiologic and clinical features. Neurology. 1985;35:1708-1713.
31. Donnan GA, McNeil JJ, Adena MA, Doyle AE, O'Malley HM, Neill GC. Smoking as a factor for cerebral ischaemia. Lancet. 1989;16:643-647.
32. Wolf PA, D'Agostino BD, Kannel WB, Bonita R, Belanger A. Cigarette smoking as a risk factor for stroke: the Framingham study. JAMA. 1988;259:1025-1029.
33. Gill JS, Shipley MJ, Tsementzis SA, Hornby RS, Gill SK, Hitchcock ER, Beevers DG. Alcohol consumption: a risk factor for hemorrhagic and non-hemorrhagic stroke. Am J Med. 1991;90:489-497.
34. Gill JS, Eezulka AV, Shipley M, Gill SK, Beevers DG. Stroke and alcohol consumption. N Engl J Med. 1986;315:1041-1046.
35. Kannel WB, Wolf PA, Verter J, McNamara PM. Epidemiologic assessment of the role of blood pressure in stroke: the Framingham study. JAMA. 1970;214:301-310.
36. Brott T, Thalinger K, Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke. 1986;17:1078-1083.
37. Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke. 1986;17: 861-864.
38. Abbott RD, Donahne RP, MacMahon SW, Reed DM, Tano K. Diabetes and the risk of stroke: the Honolulu heart program. JAMA. 1987;257:949-952.
39. Manson JE, Colditz GA, Stampfer JM, Willett WC, Krolewski AS, Rosner B, Arky RA, Speizer FE, Hennekens CH. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991;151:1141-1147.
40. Chen CJ. Blackfoot disease. Lancet. 1990;336:442. Letter.
41. Tseng CH, Chong CK, Chen CJ, Tai TY. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis. 1996;120:125-133.
42. Chen CJ, Chiou HY, Chiang MH, Lin LJ, Tai TY. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arteriosder Thromb Vasc Biol. 1996;16: 504-510.
43. Chen CJ, Chiang HC, Chiou HY, Lin KL. Surveillance Project of Underground Water Quality in Longder Area in Ilan County. Ilan County, Taiwan, ROC: Environmental Protection Bureau; 1996.
44. Lai MS, Hsueh YM, Chen CJ, Shyu MP, Chen SY, Kuo TL, Wu MM, Tai TY. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol. 1992;139:484-492.
45. Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM, Kuo TL, Tai TY. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension. 1995;25:53-60.
46. Hansen ES. Shared risk factors for cancer and atherosclerosis: a review of the epidemiological evidence. Mutat Res. 1990;239: 163-179.
47. Lilienfeld DE. Arsenic, geographical isolates, environmental epidemiology, and atherosclerosis. Arteriosclerosis. 1988;8:449-451.